Sign In
Buy RGEN
$149.78
+2.72 (+1.85%)
At Close: Aug 04, 2026
Repligen (RGEN) Q4 Earnings and Revenues Surpass Estimates
10:32am, Wednesday, 22'nd Feb 2023
Repligen (RGEN) delivered earnings and revenue surprises of 17.24% and 0.96%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Dada Nexus, Bilibili And Other Big Stocks Moving Lower On Monday
04:36pm, Monday, 30'th Jan 2023 Benzinga
U.S. stocks traded lower, with the Nasdaq Composite dropping over 100 points on Monday. Here are some big stocks recording losses in today’s session.
FiscalNote Holdings, Inc. (NYSE: NOTE) dipped 2
Moderna (MRNA) Soars 3.3%: Is Further Upside Left in the Stock?
08:10am, Thursday, 19'th Jan 2023 Zacks Investment Research
Moderna (MRNA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
Do Options Traders Know Something About Repligen (RGEN) Stock We Don't?
01:30pm, Friday, 13'th Jan 2023 Zacks Investment Research
Investors need to pay close attention to Repligen (RGEN) stock based on the movements in the options market lately.
Why Shares of Repligen Rose This Week
10:00pm, Thursday, 12'th Jan 2023 The Motley Fool
The company is coming off a solid third quarter and is getting noticed by analysts.
Why Shares of Repligen Rose This Week
05:00pm, Thursday, 12'th Jan 2023
The company is coming off a solid third quarter and is getting noticed by analysts.
HZNP vs. RGEN: Which Stock Is the Better Value Option?
04:40pm, Thursday, 12'th Jan 2023 Zacks Investment Research
HZNP vs. RGEN: Which Stock Is the Better Value Option?
HZNP vs. RGEN: Which Stock Is the Better Value Option?
12:48pm, Thursday, 12'th Jan 2023
HZNP vs. RGEN: Which Stock Is the Better Value Option?
Ranking The 10 Largest Biotechs By Pipeline
12:34pm, Wednesday, 11'th Jan 2023
The pipeline is the heart of all drug discovery companies, leading to all growth in the future. As such, understanding the relative strength of a pipeline by comparing to peers can lead to investment
Repligen Corporation to Present at 41st Annual J.P. Morgan Healthcare Conference
12:30pm, Tuesday, 03'rd Jan 2023 GlobeNewswire Inc.
WALTHAM, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at
Repligen Corporation to Present at 41st Annual J.P. Morgan Healthcare Conference
07:30am, Tuesday, 03'rd Jan 2023
WALTHAM, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at th
Repligen: Life Sciences Tools' Best Near-Cap Gain Buy
05:57am, Wednesday, 21'st Dec 2022
A 3-5 month prospect from here of RGEN share prices could reasonably range from a $156.4 low to a $190.62 high from its present $162.42 price, a +17.4% gain. 88 positions like today's in the past 5 ye
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
03:01pm, Wednesday, 14'th Dec 2022 Benzinga
Upgrades
Wolfe Research upgraded the previous rating for EQT Corp (NYSE:EQT) from Peer Perform to Outperform. EQT earned $1.04 in the third quarter, compared to $0.12 in the year-ago quarter. At the m
Despite Attractive End Markets, Analyst Outlines Concerns For Repligen Stock
06:40pm, Wednesday, 07'th Dec 2022 Benzinga
RBC Capital Markets has initiated coverage on Repligen Corporation (NASDAQ: RGEN) with a Sector Perform rating and a price target of $190.
The analyst likes the company due to product differentiat
Why Is Glaxo (GSK) Up 6.7% Since Last Earnings Report?
04:31pm, Friday, 02'nd Dec 2022 Zacks Investment Research
Glaxo (GSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
